Weijun Hu
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Potential benefits of optimised varicella vaccination scenarios in a western Chinese province: a modelling study using real-world data.
Journal: Vaccine
Published: October 15, 2025
Immunogenicity and safety of co-administration of sabin-strain-based inactivated poliovirus vaccine, diphtheria-tetanus-acellular pertussis vaccine, and live attenuated hepatitis A vaccine in 18-month-old children: A multicenter randomized controlled non-inferiority trial in China.
Journal: Vaccine
Published: August 06, 2025
WSK-V102C COVID-19 vaccine effectiveness against SARS-CoV-2 JN.1 symptomatic infection among adults 60 years and older: a prospective observational cohort study in Shaanxi Province, China, 2024.
Journal: BMC public health
Published: July 09, 2025
Immunogenicity and safety of co-administration with the Sabin-strain-based inactivated poliovirus vaccine (vero cell) and the diphtheria-tetanus-acellular pertussis vaccine in eligible children in China: a randomized, controlled, multicenter, non-inferiority trial.
Journal: Frontiers in immunology
Published: May 22, 2025
Preliminarily evaluation the safety and immunogenicity of tetanus, reduced diphtheria and acellular pertussis (five components) combined vaccine, adsorbed (Tdcp) in participants aged 6 years and above: a blinded and randomised, and controlled phase I clinical trial.
Journal: Frontiers in immunology
Published: April 23, 2025
A narrative review on the effectiveness of PPSV23 vaccination in adults in China.
Journal: Human vaccines & immunotherapeutics
Published: March 18, 2025
Immunogenicity, safety and consistency of seven lots of an inactivated COVID-19 vaccine in healthy children and adolescents: a randomized, double-blind, controlled, phase IV clinical trial.
Journal: Frontiers in immunology
Published: October 12, 2023
Impact of the COVID-19 pandemic on routine vaccination services in Shaanxi province, Northwest China: Non-pharmaceutical intervention period and mass COVID-19 vaccination period.
Journal: Human vaccines & immunotherapeutics
Published: September 04, 2023
Last Updated: 09/26/2026